I am a
Home I AM A Search Login

Papers of the Week

2022 May 27


Myocardial infarction associated with erenumab: a case report.


Perino J, Corand V, Laurent E, Théophile H, Miremont-Salamé G, Pariente A, Colas J-L, Couffinhal T, Salvo F
Pharmacotherapy. 2022 May 27.
PMID: 35620946.


Monoclonal antibodies acting on the calcitonin gene related peptide or its receptor (CGRP-mabs) are novel drugs for resistant migraine prophylaxis. As CGRP-mabs cause inhibition of vasodilatation, their use is reserved to patients with no recent history of cardiovascular diseases. We report a case of myocardial infarction associated with erenumab.